An Image/Link below is provided (as is) to download presentation
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
A client has treatment for CIN2 or CIN3, co-testing at 12months and 24 months is recommended. If both co-tests are negative, retesting in 3 years is recommended. What if the client has had 1 or 2 negative pap tests in the last 2 years but no HPV test, should we co-test for 2 years and then return to screening in 3 years?
Managing treated CIN2+
A client has treatment for CIN2 or CIN3. Client was out of program for 2 years then comes back to IBCCP, we have no record of paps or hpv during this time. Should this client be co-tested this year and next year?
Managing remotely treated CIN2+ after hysterectomy
New client age 58 reported hysterectomy due to “cysts” and no paps since. Obtained records for hysterectomy which was done 5/25/89. Per History and Physical hysterectomy was done due to severe dysplasia of cervix. Pathology results were severe dysplasia with free surgical margins. The cervix was removed. Should this client have a pap and hpv?
No diagnostic excision for cancer
The client was referred into the program with a Pap with an ASC-H (PT4) result on 1/14/2013. On 2/12/2013 the client had a colposcopy with biopsy and ECC. The results of the colposcopy were “invasive poorly differentiated non-keratinizing squamous cell carcinoma at both the 2 o’clock and 10 o’clock uterine cervix”. This was the final diagnosis and the client was approved for a medical card and later received radiation and chemo. Why didn’t they do a diagnostic excisional procedure?
AGC in women 25-29yo
Occasionally, I saw a few patients between 25-29y/o with AGC.
Since these patients can have endometrial cancer too and we do not want to miss that, should we do Colpo only or Colpo with EMB?
If the EMB is done based on the patient’s history and risk factors, are these risk factors reliable?
Is there any harm with doing the EMB at this young age range?
Since AGC could also be an indicator for other cancers of the female reproductive system, should we do more extensive tests for these patients such as pelvic ultrasound, EMB, etc…?
LSIL without CIN
49 y/o with a 2 year history of LSIL pap with benign colpow/bx.
5/2011 LSIL Pap
5/2011Colpo w/bx benign
11/2011 Negative Pap
6/2012 LSIL Pap
Client refused colpo
11/2012 LSIL Pap
1/2013Colpo w/bx benign
3/2014 LSIL HPV positive
Provider ordering treatment: cryocautery
LSIL without CIN
44 year old woman with a history of abnormal paps.
12/15/10 – Pap LSIL/+HPV
1/12/11 – colpo/biopsy negative
5/30/12 – Pap ASC-US/+HPV
6/28/12 – colpo/biopsy CIN1
1/10/13 – Pap LSIL
2/26/13 – colpo/biopsy CIN1
8/28/13 – Pap negative
She is now scheduled for cotesting this month to follow the new algorithm stating women with CIN1 preceded by “Lesser Abnormalities” should have cotesting at 12 months.
Since her follow-up pap after her 2/26/13 biopsy was only six months and didn’t include HPV we advised her to have cotesting at 12 months.